article thumbnail

Amedisys CEO Gerard ‘Terminated Without Cause;’ Kusserow to Return

Hospice News

.” Kusserow retired as CEO effective April 15 but remained chairman of the board of directors.Kusserow’s first tenure as CEO began in 2014. Under Kusserow, Amedisys also expanded its care continuum from home health and hospice to include palliative care, personal care, hospital-at-home and skilled-nursing-facility-at-home.

2014 234
article thumbnail

Amedisys Having ‘Significant Conversations’ with Prospective Palliative Care Partners

Hospice News

Kusserow – who holds a reputation as a successful turnaround executive – held the Amedisys CEO role from 2014 until early 2022. During that time, he helped spearhead the company’s aggressive hospice expansion, epitomized by the industry-shaping acquisitions of Compassionate Care Hospice, AseraCare and other businesses. “We

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Do Most People Receive Less Time in Hospice than Recommended?

1-800-HOSPICE

They were 37% more likely to say they needed more help with personal care. Families who said the hospice referral occurred too late were 119% more likely to express concerns about care coordination. Medicare Policies. Medicare and most other insurances require that people not receive cure-oriented care while in hospice.

article thumbnail

Two Hospices Halt Services Amid Staffing Shortages

Hospice News

“Like many other hospice and home health programs across the nation, as the national health care worker shortage continues and the cost of health care staff and other expenses skyrocket, we are finding it increasingly difficult to manage the rising costs of doing business.”. Personal care and social work referrals will also end.

Hospice 201
article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

In addition to acquisitions, LHC was involved in 30 out of the 69 joint ventures that completed in the hospice and home health space from 2014 to 2021, Kulik said. billion divestiture of a 60% stake in Kindred at Home’s hospice and personal care segments to the private equity firm Clayton, Dubilier & Rice. s (NYSE: HUM) $2.8

2022 215